Company / EPS (Diluted)
PALVELLA THERAPEUTICS, INC. EPS (Diluted) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$7.83
FY2024
5-year range
-$7.83 / -$0.56
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#193 of 204
Health Care
What the data says
EPS (Diluted) changed -1051% YoY in FY2024, a notable deviation from the 7-year average annual change of -154%.
Based on SEC 10-K filings.
-7.83 in FY2024.
Declined from $-0.56 to $-7.83 over the past 4 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 204This company -$7.83 Sector average -$0.98
▼
-699.3% below sector average
Key checks
Key Insights
- Ranks #193 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$7.83 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$0.68 | -21.4% |
| FY2020 | -$0.56 | -12.0% |
| FY2019 | -$0.50 | -25.0% |
| FY2018 | -$0.40 | +27.3% |
| FY2017 | -$0.55 | -34.1% |
| FY2016 | -$0.41 | +42.3% |
| FY2015 | -$0.71 | -7200.0% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026